Literature DB >> 3123611

Chorea associated with oral contraception.

D Leys1, A Destée, H Petit, P Warot.   

Abstract

Three patients developed chorea while receiving oral contraceptives. Two were young patients whose chorea developed long after treatment had been started and disappeared soon after it had been discontinued. The third patient had acute amphetamine-induced chorea after prolonged oral contraception. Prolonged administration of female sex hormones is a possible cause of chorea in women who have not previously had chorea or rheumatic fever.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123611     DOI: 10.1007/bf00314198

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

Review 1.  [Neuropharmacologic approach in Huntington's chorea].

Authors:  Y Agid
Journal:  Rev Neurol (Paris)       Date:  1975-12       Impact factor: 2.607

2.  [Huntington's disease. Contribution of clinical and epidemiological data to genetic counseling].

Authors:  H Petit; J L Salomez
Journal:  J Genet Hum       Date:  1985-06

3.  The effect of d-amphetamine on choreiform movement disorders.

Authors:  H L Klawans; W J Weiner
Journal:  Neurology       Date:  1974-04       Impact factor: 9.910

4.  Chorea and the oral contraceptives.

Authors:  A D Malcolm
Journal:  Br Med J       Date:  1971-11-20

5.  Oral contraceptive--induced chorea.

Authors:  N Kaplinsky; M Thaler; O Frankl
Journal:  Am J Obstet Gynecol       Date:  1980-09-15       Impact factor: 8.661

6.  Sydenham chorea: an update.

Authors:  P A Nausieda; B J Grossman; W C Koller; W J Weiner; H L Klawans
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

7.  [Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases].

Authors:  B Bouchez; G Arnott; P Y Hatron; A Wattel; B Devulder
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

8.  Chorea and systemic lupus erythematosus. A critical review.

Authors:  G W Bruyn; G Padberg
Journal:  Eur Neurol       Date:  1984       Impact factor: 1.710

9.  Antidopaminergic effect of estrogens at the striatal level.

Authors:  C Euvrard; C Oberlander; J R Boissier
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

10.  Estrogen in experimental tardive dyskinesia.

Authors:  J H Gordon; R L Borison; B I Diamond
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

View more
  2 in total

Review 1.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.